Search the Newsreel

Acumen Pharmaceuticals Inc (ABOS) Stock News Today

Don't Ignore The Insider Selling In Rocket Pharmaceuticals

A Chief Operating Officer at Rocket Pharmaceuticals recently sold US$128k worth of shares, representing 6.8% of their holding. This sale was the largest insider sale in the past year, though it occurred around the current market price, making it less concerning than sales at …

Meta ordered to pay $567M to address harm to New Mexico children

A New Mexico judge has ordered Meta Platforms to pay an additional $567 million to address harm to children in the state, following a jury finding that Meta's social media platforms "substantially contributed to a public nuisance." This ruling comes after an initial $375 …

Lakhbir Lamba Bought 22% More Shares In Regional Management

Lakhbir Lamba, President of Regional Management Corp. (NYSE:RM), recently increased his stake by 22%, purchasing US$316k worth of shares at US$31.65 each. While this is a strong insider buy, overall insider selling exceeded buying over the last year, though the sales were at a …

Sutro Biopharma, Inc. (NASDAQ:STRO) Just Reported And Analysts Have Been Lifting Their Price Targets

Q3 2025 Fidelity National Information Services Inc Earnings Call Transcript

This article provides the preliminary transcript for Fidelity National Information Services Inc's (FIS) Q3 2025 earnings call. FIS reported strong third-quarter results, exceeding expectations with adjusted revenue growth of 6.3% and an 8% increase in adjusted EPS year-over-year. The company raised its full-year outlook …

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

Fermi receives subpoena from US District Court for Project Matador documents

AI energy startup Fermi Inc. has received a subpoena from the US District Court for the Eastern District of New York and a document request from the SEC, both seeking records related to its ambitious Project Matador and former management. This legal pressure adds …

Benzinga Bulls and Bears: Riot Platforms, Firefly, Virgin Galactic

This article from Benzinga reviews the performance of several key stocks, highlighting both bullish and bearish sentiments from the past week. It covers Riot Platforms' Q2 success and data center deal, Firefly Aerospace's significant revenue surge, and the rebound of SpaceX shares. Conversely, it …

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

Hormel Foods (NYSE:HRL): Dividend Quality Checked, but Payout Sustainability Raises Concern

Hormel Foods (NYSE:HRL) presents an attractive dividend yield of 4.66%, significantly higher than industry and S&P 500 averages, with a consistent dividend payment history and moderate growth. However, the article highlights a major concern regarding its payout ratio of 136.95% of trailing earnings, indicating …

Technical Reactions to AVBP Trends in Macro Strategies

This article provides a technical analysis of Arrivent Biopharma Inc. (NASDAQ: AVBP) trends, highlighting neutral near and mid-term readings but a potentially strong long-term positive bias. It details institutional trading strategies, including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The …

Summit Global Investments Acquires Shares of 7,182 Vertex Pharmaceuticals Incorporated $VRTX

Summit Global Investments purchased 7,182 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in the second quarter, valued at approximately $3.57 million. Other hedge funds also adjusted their holdings, with institutional investors now owning 90.96% of the stock. Analysts currently have a "Moderate Buy" rating for VRTX …

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock

An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.

CarMax, Inc. $KMX Shares Sold by Qsemble Capital Management LP

Qsemble Capital Management LP significantly reduced its stake in CarMax, Inc. (KMX) by 81% in the second quarter, selling over 130,000 shares. Despite this, CarMax reported strong quarterly revenue of $8.01 billion and exceeded EPS estimates, though its EPS was down year-over-year. Analyst sentiment …

Cass Information Systems (NASDAQ:CASS) Lowered to "Hold" Rating by Zacks Research

Zacks Research has downgraded Cass Information Systems (NASDAQ:CASS) from a "strong-buy" to a "hold" rating. Despite this, the consensus among analysts remains a "Moderate Buy" with an average price target of $58.50. The company recently reported Q2 EPS of $0.71, slightly missing estimates, and …

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. The investigation focuses on whether Theravance's board failed to secure the best possible price, conducted a fair sales process, …

Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP

Walleye Capital LLC has acquired a new position in ANI Pharmaceuticals, purchasing 106,112 shares valued at approximately $8.8 million, indicating growing institutional interest as hedge funds and other investors collectively own 76.05% of the company. ANI Pharmaceuticals recently surpassed quarterly earnings expectations, reporting adjusted …

Spyglass Pharma (NASDAQ:SGP) Upgraded to "Moderate Buy" at Raymond James Financial

Trifecta Capital Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX

Trifecta Capital Advisors LLC has acquired a new position in Vertex Pharmaceuticals (NASDAQ:VRTX), purchasing 16,745 shares valued at approximately $8.318 million, making it their 27th largest holding. Other institutional investors like Capital Research Global Investors and State Street Corp also increased their stakes. This …

Why Is RIOT Stock Rising Despite A Big Earnings Miss?

Electrotherm Publishes Q1 FY27 Unaudited Results in Financial Express

Oppenheimer Asset Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Oppenheimer Asset Management Inc. has acquired a new stake of 17,931 shares in Vertex Pharmaceuticals (NASDAQ:VRTX), valued at approximately $8.91 million during the second quarter. This new investment comes as other institutional investors have also adjusted their holdings in VRTX. Vertex Pharmaceuticals reported earnings …

ProVise Management Group LLC Has $282,000 Position in CarMax, Inc. $KMX

ProVise Management Group LLC significantly reduced its stake in CarMax, Inc. (NYSE:KMX) by 95.2% in the second quarter, now holding 5,340 shares valued at $282,000. Despite this, other hedge funds increased their positions in CarMax, with notable acquisitions by SRS Investment Management LLC and …

86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC

Walleye Capital LLC has acquired 86,249 shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) during the second quarter, valued at approximately $3.12 million, representing a 0.31% stake in the company. This acquisition comes as Eton Pharmaceuticals reported strong quarterly results, exceeding revenue and EPS expectations, and …

Quantinno Capital Management LP Buys 24,878 Shares of Crinetics Pharmaceuticals, Inc. $CRNX

Quantinno Capital Management LP significantly increased its stake in Crinetics Pharmaceuticals, Inc. (CRNX) by 280.9% in Q1, acquiring an additional 24,878 shares to reach a total of 33,734 shares valued at $1.225 million. This comes as Crinetics Pharmaceuticals reported strong Q1 revenues of $25.12 …

California State Teachers Retirement System Grows Stock Holdings in Urogen Pharma $URGN

The California State Teachers Retirement System significantly increased its holdings in Urogen Pharma (NASDAQ:URGN) by 1,605.5% in the first quarter, now owning 38,750 shares valued at $697,000. Institutional investors collectively hold 91.29% of the company, which has an average analyst rating of "Moderate Buy" …

How Investors May Respond To ANI Pharmaceuticals (ANIP) Record Q2 Results And Reaffirmed 2026 Revenue Guidance

Crinetics Pharmaceuticals (CRNX) Reports Q2 2026 Results, Is The Stock About Right?

ARS Pharmaceuticals (SPRY) Stock Faces Margin Squeeze As Losses Deepen

How New Mexico’s $567 Million Ruling Could Change Meta

A New Mexico judge has imposed Meta Platforms, Inc. (NASDAQ:META)'s highest single penalty yet in the wave of litigation over social media's effects on children, and while the monetary amount is making headlines, the more important aspect of the verdict may be what it …

Walleye Capital LLC Invests $4.84 Million in Xeris Biopharma Holdings, Inc. $XERS

Walleye Capital LLC has invested $4.84 million in Xeris Biopharma Holdings, Inc. by acquiring 611,296 shares in the second quarter, representing 0.35% of the company. Institutional investors collectively own 42.75% of Xeris. Despite reporting higher-than-expected revenue of $92.1 million, the company posted an adjusted …

Permianville: Q2 Earnings Snapshot

Permianville Royalty Trust (PVL) reported net income of $1.1 million, or 3 cents per share, for its second quarter. The Houston-based oil and gas trust also posted revenue of $14.8 million for the period. This financial report was generated using data from Zacks Investment …

Walleye Capital LLC Buys New Position in Xenon Pharmaceuticals Inc. $XENE

Walleye Capital LLC has acquired a new position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE), purchasing 76,955 shares valued at approximately $4.65 million. This move is amidst positive analyst sentiment with a "Buy" rating and a $77.13 average price target, despite recent insider stock sales totaling …